Zhao, Xinge published the artcileDiscovery of novel Bruton’s tyrosine kinase (BTK) inhibitors bearing a pyrrolo[2,3-d]pyrimidine scaffold, Application In Synthesis of 724710-02-5, the publication is Bioorganic & Medicinal Chemistry (2015), 23(4), 891-901, database is CAplus and MEDLINE.
A series of novel reversible BTK inhibitors was designed based on the structure of the recently reported preclin. drug RN486. Knowledge of the binding mode of RN486 led to the design of new inhibitors that utilized pyrrolo[2,3-d]pyrimidine to conformationally restrain key pharmacophoric groups within the mol. Comprehensive SAR was disclosed and the most promising compound 4x displayed superior activity both in BTK enzyme (IC50 = 4.8 nM) and cellular inhibition (IC50 = 17 nM) assays to that of RN486.
Bioorganic & Medicinal Chemistry published new progress about 724710-02-5. 724710-02-5 belongs to pyrazoles-derivatives, auxiliary class Pyrazole,Boronic acid and ester,Pyrazole,Boronic Acids,Boronic acid and ester, name is (1H-Pyrazol-5-yl)boronic acid, and the molecular formula is C5H8N2O, Application In Synthesis of 724710-02-5.
Referemce:
https://en.wikipedia.org/wiki/Pyrazole,
Pyrazoles – an overview | ScienceDirect Topics